Copyright
©The Author(s) 2023.
World J Gastroenterol. Apr 7, 2023; 29(13): 2034-2049
Published online Apr 7, 2023. doi: 10.3748/wjg.v29.i13.2034
Published online Apr 7, 2023. doi: 10.3748/wjg.v29.i13.2034
Indicator | TEN (n = 10) | TPN (n = 10) | SPN (n = 10) | H/F/χ2/Z/t value | P value |
Age (yr, mean ± SD) | 59.20 ± 12.52 | 54.30 ± 15.10 | 59.30 ± 16.33 | 0.46 | 0.63 |
Sex | |||||
Male (case, %) | 8 (80) | 8 (80) | 8 (80) | 0.00 | 1.00 |
Female (case, %) | 2 (20) | 2 (20) | 2 (20) | ||
Underlying disease | |||||
Hypertension (case, %) | 4 (40) | 3 (30) | 5 (50) | 0.83 | 0.65 |
Diabetes (case, %) | 2 (20) | 4 (40) | 2 (20) | 1.36 | 0.50 |
Malignant tumor (case, %) | 0 (0) | 2 (20) | 2 (20) | 2.30 | 0.31 |
APACHE II score on day 1 (points, mean ± SD) | 14.10 ± 2.84 | 15.30 ± 4.73 | 19.50 ± 7.38 | 2.12 | 0.14 |
SOFA score on day 1 (points, mean ± SD) | 5.40 ± 1.51 | 9.60 ± 1.95 | 10.20 ± 4.10 | 5.53 | 0.10 |
BMI (kg/m2, mean ± SD) | 23.90 ± 2.79 | 26.84 ± 3.89 | 26.05 ± 2.67 | 1.90 | 0.17 |
NUTRIC score on day 1 | |||||
≥ 6 points (case, %) | 3 (30) | 6 (60) | 6 (60) | 2.40 | 0.30 |
< 6 points (case, %) | 7 (70) | 4 (40) | 4 (40) | ||
REE on day 1 [kcal, M (P25, P75)] | 1950.00 (1759.28, 2050.72) | 1900 (1726.40, 2073.59) | 2036 (1882.46, 2189.53) | 2.49 | 0.28 |
Indicator | TEN (n = 20) | SPN (n = 20) | TPN (n = 20) | |||||||||
Day 1 (n = 10) | Day 5 (n = 10) | t/Z value | P value | Day 1 (n = 10) | Day 5 (n = 10) | t/Z value | P value | Day 1 (n = 10) | Day 5 (n = 10) | t/Z value | P value | |
CD3+ T cell [%, M (P25, P75)] | 69.85 (63.62, 78.77) | 77.77 (69.40, 80.48) | 2.09 | 0.03 | 71.33 (64.42, 76.50) | 72.25 (64.59, 82.59) | 1.78 | 0.07 | 74.21 (59.82, 83.43) | 74.80 (67.23, 82.74) | 0.76 | 0.44 |
CD3+ CD4+ T cell [%, M (P25, P75)] | 36.40 (29.47, 43.39) | 40.39 (36.96, 46.50) | 1.98 | 0.04 | 38.21 (32.22, 57.15) | 47.37 (35.61, 58.27) | 1.17 | 0.24 | 38.12 (29.23, 46.40) | 45.67 (28.13, 51.69) | 1.37 | 0.16 |
CD19+ B cell [%, M (P25, P75)] | 17.04 (11.55, 21.27) | 14.11 (8.99, 18.03) | 1.98 | 0.04 | 16.80 (10.70, 25.14) | 9.75 (6.47, 16.59) | 2.09 | 0.03 | 14.35 (6.62, 22.89) | 12.78 (6.93, 23.61) | 1.02 | 0.30 |
IgA (g/L mean ± SD) | 2.53 ± 1.18 | 2.93 ± 0.93 | 1.97 | 0.08 | 2.15 ± 0.83 | 2.91 ± 1.19 | 3.87 | 0.00 | 2.10 ± 1.13 | 2.45 ± 0.73 | 1.44 | 0.18 |
IgG (g/L, mean ± SD) | 11.75 ± 3.46 | 15.19 ± 5.84 | 3.10 | 0.01 | 9.05 ± 3.78 | 13.77 ± 4.52 | 5.48 | 0.00 | 9.32 ± 3.89 | 12.15 ± 3.85 | 3.48 | 0.00 |
IgM (g/L, mean ± SD) | 0.81 ± 0.36 | 1.11 ± 0.48 | 1.49 | 0.16 | 0.95 ± 0.44 | 1.12 ± 0.75 | 1.11 | 0.29 | 0.77 ± 3.89 | 0.89 ± 0.46 | 1.02 | 0.33 |
C3 (g/L, mean ± SD) | 0.99 ± 0.30 | 1.21 ± 0.23 | 2.84 | 0.01 | 0.81 ± 0.21 | 1.07 ± 0.23 | 4.73 | 0.00 | 0.77 ± 0.25 | 0.88 ± 0.33 | 0.95 | 0.36 |
C4 (g/L, mean ± SD) | 0.19 ± 0.04 | 0.22 ± 0.05 | 2.08 | 0.06 | 0.19 ± 0.07 | 0.22 ± 0.07 | 3.64 | 0.00 | 0.17 ± 0.05 | 0.21 ± 0.08 | 1.75 | 0.11 |
Albumin (g/L, mean ± SD) | 27.14 ± 3.18 | 29.89 ± 3.61 | 3.04 | 0.01 | 27.74 ± 3.45 | 30.97 ± 2.63a | 2.68 | 0.02 | 28.10 ± 3.37 | 27.73 ± 2.64 | 0.24 | 0.81 |
Pre-albumin (g/L, mean ± SD) | 0.10 ± 0.04 | 0.15 ± 0.07a | 3.88 | 0.00 | 0.08 ± 0.41 | 0.13 ± 0.05 | 3.42 | 0.00 | 0.10 ± 0.03 | 0.11 ± 0.03 | 0.47 | 0.64 |
Transferrin (g/L, mean ± SD) | 0.01 ± 0.28 | 0.01 ± 0.28 | 1.52 | 0.15 | 1.16 ± 0.36 | 1.36 ± 0.51 | 2.67 | 0.02 | 1.05 ± 0.30 | 1.20 ± 0.37 | 1.11 | 0.29 |
- Citation: Yang XJ, Wang XH, Yang MY, Ren HY, Chen H, Zhang XY, Liu QF, Yang G, Yang Y, Yang XJ. Exploring choices of early nutritional support for patients with sepsis based on changes in intestinal microecology. World J Gastroenterol 2023; 29(13): 2034-2049
- URL: https://www.wjgnet.com/1007-9327/full/v29/i13/2034.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i13.2034